NASDAQ : CTMX

CytomX Therapeutics, Inc.

$3.5706 USD

-$0.11 (-2.97%)

Volume
1.08M
Average Volume
4.22M
Market Capitalization
$574.24M
P/E Ratio
-9.89
Dividend Yield
0.00%
Price Target
$10.00
Year High
$8.21
Year Low
$1.72
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$10.38
Analyst Rating

Sell

2 Rating Score

UPSIDE/DOWNSIDE

-64.3% DOWNSIDE

$10.00 Price Target

UPSIDE/DOWNSIDE HIGH

-77.7% DOWNSIDE

$16.00 Price Target High

UPSIDE/DOWNSIDE LOW

-40.5% DOWNSIDE

$6.00 Price Target Low

CTMX Upgrades Downgrades Consensus

Overall Consensus: Buy  |  Total Analysts: 21

Strong Buy Buy Hold Sell Strong Sell
0 17 4 0 0
Analyst Company Analyst Name Price Target Price When Posted Date Upside/Downside
Jefferies Roger Song $16 $4.605 2026-03-18 10:16 AM 247.4%
Oppenheimer Matthew Biegler $12 $8.025 2026-03-16 09:30 AM 49.5%
Guggenheim Michael Schmidt $10 $5.39 2026-01-20 06:48 AM 85.5%
Barclays Etzer Darout $8 $5.39 2026-01-20 06:37 AM 48.4%
Barclays Etzer Darout $6 $3.74 2025-10-21 05:19 AM 60.4%
Barclays Etzer Darout $3.5 $1.96 2025-09-16 04:46 PM 78.6%